As discussed in Note 1, we identified errors in our consolidated financial statements for fiscal years ended 2022 and 2021 and for the quarterly periods of 2023. A summary of the corrections, inclusive of adjustments discovered in the third and fourth quarters of 2023, are as follows (tables may not foot or cross foot due to rounding):


Condensed Consolidated Balance Sheet
January 1, 2022
	As Previously Reported		Adjustments		As Corrected
Assets
Cash and cash equivalents	$	601,428	$	(13,378)	$	588,050
Receivables, net	782,785		(28,671)		754,114
Inventories, net	4,659,018		23,617		4,682,635

Total current assets	6,275,476		(18,432)		6,257,044





Total assets	$	12,194,209	$	(18,432)	$	12,175,777

Liabilities and Stockholders’ Equity
Accounts payable	$	3,922,007	$	44,567	$	3,966,574
Accrued expenses	777,051		(2,902)		774,149

Total current liabilities	5,180,307		41,665		5,221,972


Deferred income taxes	410,606		(15,438)		395,168
Other long-term liabilities	103,034		1,840		104,874
Total liabilities	9,065,918		28,067		9,093,985




Accumulated other comprehensive loss	(22,627)		(4,432)		(27,059)
Retained earnings	4,605,791		(42,067)		4,563,724
Total stockholders’ equity	3,128,291		(46,499)		3,081,792
Total liabilities and stockholders’ equity	$	12,194,209	$	(18,432)	$	12,175,777


Condensed Consolidated Balance Sheet
December 31, 2022
	As Previously Reported		Adjustments		As Corrected
Assets
Cash and cash equivalents	$	269,282	$	1,523	$	270,805
Receivables, net	698,613		(14,565)		684,048
Inventories, net	4,915,262		(18,993)		4,896,269

Total current assets	6,046,852		(32,035)		6,014,817





Total assets	$	12,018,482	$	(32,035)	$	11,986,447

Liabilities and Stockholders’ Equity
Accounts payable	$	4,123,462	$	55,445	$	4,178,907
Accrued expenses	634,447		(4,983)		629,464


Total current liabilities	5,370,389		50,462		5,420,851


Deferred income taxes	415,997		(5,248)		410,749
Other long-term liabilities	87,214		1,840		89,054
Total liabilities	9,340,201		47,054		9,387,255




Accumulated other comprehensive loss	(45,143)		448		(44,695)
Retained earnings	4,744,624		(79,537)		4,665,087
Total stockholders’ equity	2,678,281		(79,089)		2,599,192
Total liabilities and stockholders’ equity	$	12,018,482	$	(32,035)	$	11,986,447


Condensed Consolidated Balance Sheet
April 22, 2023
	As Previously Reported		Adjustments		As Corrected
Assets
Cash and cash equivalents	$	226,499	$	(2,619)	$	223,880
Receivables, net	782,093		(12,107)		769,986
Inventories, net	5,015,973		(14,816)		5,001,157
Other current assets	177,127		24,590		201,717
Total current assets	6,201,692		(4,952)		6,196,740





Total assets	$	12,182,238	$	(4,952)	$	12,177,286

Liabilities and Stockholders’ Equity
Accounts payable	$	3,682,749	$	72,249	$	3,754,998
Accrued expenses	718,290		(352)		717,938


Total current liabilities	4,983,455		71,897		5,055,352


Deferred income taxes	422,984		(5,248)		417,736
Other long-term liabilities	85,762		1,840		87,602
Total liabilities	9,546,077		68,489		9,614,566




Accumulated other comprehensive loss	(44,355)		424		(43,931)
Retained earnings	4,697,697		(73,865)		4,623,832
Total stockholders’ equity	2,636,161		(73,441)		2,562,720
Total liabilities and stockholders’ equity	$	12,182,238	$	(4,952)	$	12,177,286


Condensed Consolidated Balance Sheet
July 15, 2023
	As Previously Reported		Adjustments		As Corrected
Assets
Cash and cash equivalents	$	277,064	$	(1,838)	$	275,226
Receivables, net	793,772		(11,081)		782,691
Inventories, net	5,067,467		(15,223)		5,052,244
Other current assets	188,169		22,988		211,157
Total current assets	6,326,472		(5,154)		6,321,318





Total assets	$	12,304,376	$	(5,154)	$	12,299,222

Liabilities and Stockholders’ Equity
Accounts payable	$	3,780,215	$	82,467	$	3,862,682
Accrued expenses	685,191		(7,088)		678,103


Total current liabilities	5,026,378		75,379		5,101,757




Total liabilities	9,581,189		75,379		9,656,568




Accumulated other comprehensive loss	(36,824)		117		(36,707)
Retained earnings	4,767,168		(80,650)		4,686,518
Total stockholders’ equity	2,723,187		(80,533)		2,642,654
Total liabilities and stockholders’ equity	$	12,304,376	$	(5,154)	$	12,299,222


Condensed Consolidated Balance Sheet
October 7, 2023
	As Previously Reported		Adjustments		As Corrected
Assets
Cash and cash equivalents	$	317,528	$	(974)	$	316,554
Receivables, net	868,305		(5,045)		863,260
Inventories, net	4,949,382		(30,227)		4,919,155
Other current assets	185,249		36,475		221,724
Total current assets	6,320,464		229		6,320,693





Total assets	$	12,248,932	$	229	$	12,249,161

Liabilities and Stockholders’ Equity
Accounts payable	$	3,943,019	$	70,995	$	4,014,014
Accrued expenses	714,317		9,766		724,083


Total current liabilities	5,135,939		80,761		5,216,700




Total liabilities	9,602,064		80,761		9,682,825




Accumulated other comprehensive loss	(47,599)		574		(47,025)
Retained earnings	4,690,424		(81,106)		4,609,318
Total stockholders’ equity	2,646,868		(80,532)		2,566,336
Total liabilities and stockholders’ equity	$	12,248,932	$	229	$	12,249,161


Condensed Consolidated Statement of Operations
January 1, 2022
	Year Ended
	As Previously Reported		Adjustments		As Corrected
Cost of sales	$	6,069,241	$	4,798	$	6,074,039
Gross profit	4,928,748		(4,798)		4,923,950
Selling, general and administrative expenses	4,090,031		11,554		4,101,585
Operating income	838,717		(16,352)		822,365



Other (expense) income, net	4,999		(7,080)		(2,081)
Total other, net	(32,792)		(7,080)		(39,872)
Income before provision for income taxes	805,925		(23,432)		782,493
Provision for income taxes	189,817		(3,939)		185,878
Net income	$	616,108	$	(19,493)	$	596,615

Basic earnings per share	$	9.62	$	(0.30)	$	9.32


Diluted earnings per common share	$	9.55	$	(0.30)	$	9.25


Condensed Consolidated Statement of Operations
December 31, 2022
	Year Ended
	As Previously Reported		Adjustments		As Corrected
Cost of sales	$	6,192,622	$	29,865	$	6,222,487
Gross profit	4,962,100		(29,865)		4,932,235
Selling, general and administrative expenses	4,247,949		14,033		4,261,982
Operating income	714,151		(43,898)		670,253



Other (expense) income, net	(6,996)		(427)		(7,423)
Total other, net	(65,464)		(427)		(65,891)
Income before provision for income taxes	648,687		(44,325)		604,362
Provision for income taxes	146,815		(6,855)		139,960
Net income	$	501,872	$	(37,470)	$	464,402

Basic earnings per share	$	8.32	$	(0.62)	$	7.70


Diluted earnings per common share	$	8.27	$	(0.62)	$	7.65


Condensed Consolidated Statement of Operations
April 22, 2023
	Sixteen Weeks Ended
	As Previously Reported		Adjustments		As Corrected
Cost of sales	$	1,946,931	$	8,735	$	1,955,666
Gross profit	1,470,663		(8,735)		1,461,928
Selling, general and administrative expenses	1,380,664		(16,674)		1,363,990
Operating income	89,999		7,939		97,938





Income before provision for income taxes	59,607		7,939		67,546
Provision for income taxes	16,956		2,267		19,223
Net income	$	42,651	$	5,672	$	48,323

Basic earnings per share	$	0.72	$	0.09	$	0.81


Diluted earnings per common share	$	0.72	$	0.09	$	0.81


Condensed Consolidated Statement of Operations
July 15, 2023
	Twelve Weeks Ended						Twenty-Eight Weeks Ended
	As Previously Reported		Adjustments		As Corrected		As Previously Reported		Adjustments		As Corrected
Cost of sales	$	1,537,997	$	7,614	$	1,545,611	$	3,484,927	$	16,350	$	3,501,277
Gross profit	1,148,069		(7,614)		1,140,455		2,618,732		(16,350)		2,602,382
Selling, general and administrative expenses	1,013,701		794		1,014,495		2,394,365		(15,881)		2,378,484
Operating income	134,368		(8,408)		125,960		224,367		(469)		223,898





Income before provision for income taxes	115,183		(8,408)		106,775		174,789		(469)		174,320
Provision for income taxes	29,821		(1,623)		28,198		46,776		644		47,420
Net income	$	85,362	$	(6,785)	$	78,577	$	128,013	$	(1,113)	$	126,900

Basic earnings per share	$	1.44	$	(0.12)	$	1.32	$	2.16	$	(0.02)	$	2.14


Diluted earnings per common share	$	1.43	$	(0.11)	$	1.32	$	2.15	$	(0.02)	$	2.13


Condensed Consolidated Statement of Operations
October 7, 2023
	Twelve Weeks Ended						Forty Weeks Ended
	As Previously Reported		Adjustments		As Corrected		As Previously Reported		Adjustments		As Corrected
Cost of sales	$	1,732,420	$	16,379	$	1,748,799	$	5,220,200	$	29,877	$	5,250,077
Gross profit	986,659		(16,379)		970,280		3,602,538		(29,877)		3,572,661
Selling, general and administrative expenses	1,030,355		878		1,031,233		3,407,445		2,272		3,409,717
Operating (loss) income	(43,696)		(17,257)		(60,953)		195,093		(32,149)		162,944





(Loss) income before provision for income taxes	(64,319)		(17,257)		(81,576)		124,894		(32,149)		92,745
Provision for income taxes	(15,686)		(3,853)		(19,539)		34,649		(6,766)		27,883
Net (loss) income	$	(48,633)	$	(13,404)	$	(62,037)	$	90,245	$	(25,383)	$	64,862

Basic (loss) earnings per share	$	(0.82)	$	(0.22)	$	(1.04)	$	1.52	$	(0.43)	$	1.09


Diluted (loss) earnings per common share	$	(0.82)	$	(0.22)	$	(1.04)	$	1.51	$	(0.42)	$	1.09


Condensed Consolidated Statement of Comprehensive Income
January 1, 2022
	Year Ended
	As Previously Reported		Adjustments		As Corrected
Net income	$	616,108	$	(19,493)	$	596,615
Currency translation adjustments	4,396		(4,455)		(59)
Total other comprehensive income (loss)	4,132		(4,455)		(323)
Comprehensive income	$	620,240	$	(23,948)	$	596,292


Condensed Consolidated Statement of Comprehensive Income
December 31, 2022
	Year Ended
	As Previously Reported		Adjustments		As Corrected
Net income	$	501,872	$	(37,470)	$	464,402
Currency translation adjustments	(22,330)		4,880		(17,450)
Total other comprehensive loss	(22,516)		4,880		(17,636)
Comprehensive income	$	479,356	$	(32,590)	$	446,766


Condensed Consolidated Statement of Comprehensive Income
April 22, 2023
	Sixteen Weeks Ended
	As Previously Reported		Adjustments		As Corrected
Net income	$	42,651	$	5,672	$	48,323
Currency translation adjustments	591		(24)		567
Total other comprehensive loss	788		(24)		764
Comprehensive income	$	43,439	$	5,648	$	49,087


Condensed Consolidated Statement of Comprehensive Income
July 15, 2023
	Twelve Weeks Ended						Twenty-Eight Weeks Ended
	As Previously Reported		Adjustments		As Corrected		As Previously Reported		Adjustments		As Corrected
Net income	$	85,362	$	(6,785)	$	78,577	$	128,013	$	(1,113)	$	126,900
Currency translation adjustments	7,569		(307)		7,262		8,160		(331)		7,829
Total other comprehensive income	7,531		(307)		7,224		8,319		(331)		7,988
Comprehensive income	$	92,893	$	(7,092)	$	85,801	$	136,332	$	(1,444)	$	134,888


Condensed Consolidated Statement of Comprehensive Income
October 7, 2023
	Twelve Weeks Ended						Forty Weeks Ended
	As Previously Reported		Adjustments		As Corrected		As Previously Reported		Adjustments		As Corrected
Net (loss) income	$	(48,633)	$	(13,404)	$	(62,037)	$	90,245	$	(25,383)	$	64,862
Currency translation adjustments	(10,737)		457		(10,280)		(2,577)		126		(2,451)
Total other comprehensive loss	(10,775)		457		(10,318)		(2,456)		126		(2,330)
Comprehensive (loss) income	$	(59,408)	$	(12,947)	$	(72,355)	$	87,789	$	(25,257)	$	62,532


Condensed Consolidated Statements of Changes in Stockholders’ Equity
	Accumulated Other Comprehensive Loss		Retained Earnings		Total Stockholders' Equity
Fifty-Two Weeks As Previously Reported
Balance at January 2, 2021	$	(26,759)	$	4,196,634	$	3,559,512
Net income	—		616,108		616,108
Total other comprehensive income	4,132		—		4,132
Balance at January 1, 2022	$	(22,627)	$	4,605,791	$	3,128,291
Adjustments
Balance at January 2, 2021	$	23	$	(22,574)	$	(22,551)
Net Income	—		(19,493)		(19,493)
Total other comprehensive income	(4,455)		—		(4,455)
Balance at January 1, 2022	$	(4,432)	$	(42,067)	$	(46,499)
As Corrected
Balance at January 2, 2021	$	(26,736)	$	4,174,060	$	3,536,961
Net income	—		596,615		596,615
Total other comprehensive loss	(323)		—		(323)
Balance at January 1, 2022	$	(27,059)	$	4,563,724	$	3,081,792


Condensed Consolidated Statements of Changes in Stockholders’ Equity
	Accumulated Other Comprehensive Loss		Retained Earnings		Total Stockholders' Equity
Fifty-Two Weeks As Previously Reported
Balance at January 1, 2022	$	(22,627)	$	4,605,791	$	3,128,291
Net income	—		501,872		501,872
Total other comprehensive loss	(22,516)		—		(22,516)
Balance at December 31, 2022	$	(45,143)	$	4,744,624	$	2,678,281
Adjustments
Balance at January 1, 2022	$	(4,432)	$	(42,067)	$	(46,499)
Net Income	—		(37,470)		(37,470)
Total other comprehensive loss	4,880		—		4,880
Balance at December 31, 2022	$	448	$	(79,537)	$	(79,089)
As Corrected
Balance at January 1, 2022	$	(27,059)	$	4,563,724	$	3,081,792
Net income	—		464,402		464,402
Total other comprehensive loss	(17,636)		—		(17,636)
Balance at December 31, 2022	$	(44,695)	$	4,665,087	$	2,599,192


Condensed Consolidated Statements of Changes in Stockholders’ Equity
Sixteen Weeks Ended April 22, 2023
	Accumulated Other Comprehensive Loss		Retained Earnings		Total Stockholders' Equity
Sixteen Weeks As Previously Reported
Balance at December 31, 2022	$	(45,143)	$	4,744,624	$	2,678,281
Net income	—		42,651		42,651
Total other comprehensive income	788		—		788
Balance at April 22, 2023	$	(44,355)	$	4,697,697	$	2,636,161
Adjustments
Balance at December 31, 2022	$	448	$	(79,537)	$	(79,089)
Net income	—		5,672		5,672
Total other comprehensive income	(24)		—		(24)
Balance at April 22, 2023	$	424	$	(73,865)	$	(73,441)
As Corrected
Balance at December 31, 2022	$	(44,695)	$	4,665,087	$	2,599,192
Net income	—		48,323		48,323
Total other comprehensive income	764		—		764
Balance at April 22, 2023	$	(43,931)	$	4,623,832	$	2,562,720


Condensed Consolidated Statements of Changes in Stockholders’ Equity
Twelve Weeks Ended July 15, 2023
	Accumulated Other Comprehensive Loss		Retained Earnings		Total Stockholders' Equity
Twelve Weeks As Previously Reported
Balance at April 22, 2023	$	(44,355)	$	4,697,697	$	2,636,161
Net income	—		85,362		85,362
Total other comprehensive income	7,531		—		7,531
Balance at July 15, 2023	$	(36,824)	$	4,767,168	$	2,723,187
Adjustments
Balance at April 22, 2023	$	424	$	(73,865)	$	(73,441)
Net income	—		(6,785)		(6,785)
Total other comprehensive income	(307)		—		(307)
Balance at July 15, 2023	$	117	$	(80,650)	$	(80,533)
As Corrected
Balance at April 22, 2023	$	(43,931)	$	4,623,832	$	2,562,720
Net income	—		78,577		78,577
Total other comprehensive income	7,224		—		7,224
Balance at July 15, 2023	$	(36,707)	$	4,686,518	$	2,642,654


Condensed Consolidated Statements of Changes in Stockholders’ Equity
Twenty-Eight Weeks Ended July 15, 2023
	Accumulated Other Comprehensive Loss		Retained Earnings		Total Stockholders' Equity
Twenty-Eight Weeks As Previously Reported
Balance at Dec 31, 2022	$	(45,143)	$	4,744,624	$	2,678,281
Net income	—		128,013		128,013
Total other comprehensive income	8,319		—		8,319
Balance at July 15, 2023	$	(36,824)	$	4,767,168	$	2,723,187
Adjustments
Balance at Dec 31, 2022	$	448	$	(79,537)	$	(79,089)
Net income	—		(1,113)		(1,113)
Total other comprehensive income	(331)		—		(331)
Balance at July 15, 2023	$	117	$	(80,650)	$	(80,533)
As Corrected
Balance at Dec 31, 2022	$	(44,695)	$	4,665,087	$	2,599,192
Net income	—		126,900		126,900
Total other comprehensive income	7,988		—		7,988
Balance at July 15, 2023	$	(36,707)	$	4,686,518	$	2,642,654


Condensed Consolidated Statements of Changes in Stockholders’ Equity
Twelve Weeks Ended October 7, 2023
	Accumulated Other Comprehensive Loss		Retained Earnings		Total Stockholders' Equity
Twelve Weeks As Previously Reported
Balance at July 15, 2023	$	(36,824)	$	4,767,168	$	2,723,187
Net loss	—		(48,633)		(48,633)
Total other comprehensive loss	(10,775)		—		(10,775)
Balance at October 7, 2023	$	(47,599)	$	4,690,424	$	2,646,868
Adjustments
Balance at July 15, 2023	$	117	$	(80,650)	$	(80,533)
Net loss (1)	—		(13,404)		(13,404)
Total other comprehensive loss	457		—		457
Balance at October 7, 2023	$	574	$	(81,106)	$	(80,532)
As Corrected
Balance at July 15, 2023	$	(36,707)	$	4,686,518	$	2,642,654
Net loss	—		(62,037)		(62,037)
Total other comprehensive loss	(10,318)		—		(10,318)
Balance at October 7, 2023	$	(47,025)	$	4,609,318	$	2,566,336


Condensed Consolidated Statements of Changes in Stockholders’ Equity
Forty Weeks Ended October 7, 2023
	Accumulated Other Comprehensive Loss		Retained Earnings		Total Stockholders' Equity
Forty Weeks As Previously Reported
Balance at December 31, 2022	$	(45,143)	$	4,744,624	$	2,678,281
Net income	—		90,245		90,245
Total other comprehensive loss	(2,456)		—		(2,456)
Balance at October 7, 2023	$	(47,599)	$	4,690,424	$	2,646,868
Adjustments
Balance at December 31, 2022	$	448	$	(79,537)	$	(79,089)
Net income (1)	—		(25,383)		(25,383)
Total other comprehensive loss	126		—		126
Balance at October 7, 2023	$	574	$	(81,106)	$	(80,532)
As Corrected
Balance at December 31, 2022	$	(44,695)	$	4,665,087	$	2,599,192
Net income	—		64,862		64,862
Total other comprehensive loss	(2,330)		—		(2,330)
Balance at October 7, 2023	$	(47,025)	$	4,609,318	$	2,566,336


Condensed Consolidated Statement of Cash Flows
Fifty-Two Weeks Ended January 1, 2022
	As Previously Reported		Adjustments		As Corrected
Net income	$	616,108	$	(19,493)	$	596,615
Provision for deferred income taxes	68,202		(9,416)		58,786
Net change in:
Receivables, net	(32,652)		25,196		(7,456)
Inventories, net	(120,272)		(3,867)		(124,139)
Accounts payable	281,064		9,978		291,042
Accrued expenses	109,983		(7,638)		102,345
Net cash provided by operating activities	1,112,262		(5,240)		1,107,022
Effect of exchange rate changes on cash	5,600		(126)		5,474
Net (decrease) increase in cash and cash equivalents	(233,564)		(5,366)		(238,930)
Cash and cash equivalents, beginning of period	834,992		(8,012)		826,980
Cash and cash equivalents, end of period	$	601,428	$	(13,378)	$	588,050


Condensed Consolidated Statement of Cash Flows
Fifty-Two Weeks Ended December 31, 2022
	As Previously Reported		Adjustments		As Corrected
Net income	$	501,872	$	(37,470)	$	464,402
Provision for deferred income taxes	6,338		10,190		16,528
Net change in:
Receivables, net	81,254		(14,107)		67,147
Inventories, net	(272,253)		42,610		(229,643)
Accounts payable	212,568		15,206		227,774
Accrued expenses	(165,643)		(2,080)		(167,723)

Net cash provided by operating activities	722,222		14,349		736,571


Effect of exchange rate changes on cash	(9,216)		552		(8,664)
Net (decrease) increase in cash and cash equivalents	(332,146)		14,901		(317,245)
Cash and cash equivalents, beginning of period	601,428		(13,378)		588,050
Cash and cash equivalents, end of period	$	269,282	$	1,523	$	270,805


Condensed Consolidated Statement of Cash Flows
Sixteen Weeks Ended April 22, 2023
	As Previously Reported		Adjustments		As Corrected
Net income	$	42,651	$	5,672	$	48,323
Other, net	391		458		849
Net change in:
Receivables, net	(83,370)		(2,457)		(85,827)
Inventories, net	(100,178)		(4,177)		(104,355)
Accounts payable	(440,995)		16,805		(424,190)
Accrued expenses	85,035		4,631		89,666
Other assets and liabilities, net	1,534		(24,591)		(23,057)
Net cash used in operating activities	(378,865)		(3,659)		(382,524)
Other, net	(3,919)		(458)		(4,377)
Net cash used in financing activities	425,660		(458)		425,202
Effect of exchange rate changes on cash	93		(25)		68
Net (decrease) increase in cash and cash equivalents	(42,783)		(4,142)		(46,925)
Cash and cash equivalents, beginning of period	269,282		1,523		270,805
Cash and cash equivalents, end of period	$	226,499	$	(2,619)	$	223,880


Condensed Consolidated Statement of Cash Flows
Twenty-Eight Weeks Ended July 15, 2023
	As Previously Reported		Adjustments		As Corrected
Net income	$	128,013	$	(1,113)	$	126,900
Provision for deferred income taxes	16,249		$	5,248	$	21,497
Other, net	1,170		$	458	$	1,628
Net change in:
Receivables, net	(93,539)		(3,483)		(97,022)
Inventories, net	(145,148)		(3,770)		(148,918)
Accounts payable	(346,808)		27,023		(319,785)
Accrued expenses	120,888		(2,107)		118,781
Other assets and liabilities, net	(36,008)		(24,828)		(60,836)
Net cash used in operating activities	(164,559)		(2,572)		(167,131)
Other, net	(4,073)		(458)		(4,531)
Net cash used in financing activities	314,403		(458)		313,945
Effect of exchange rate changes on cash	1,280		(331)		949
Net (decrease) increase in cash and cash equivalents	7,782		(3,361)		4,421
Cash and cash equivalents, beginning of period	269,282		1,523		270,805
Cash and cash equivalents, end of period	$	277,064	$	(1,838)	$	275,226


Condensed Consolidated Statement of Cash Flows
Forty Weeks Ended October 7, 2023
	As Previously Reported		Adjustments		As Corrected
Net income	$	90,245	$	(25,383)	$	64,862
Provision for deferred income taxes	(33,059)		5,248		(27,811)
Other, net	1,499		937		2,436
Net change in:
Receivables, net	(170,371)		(9,519)		(179,890)
Inventories, net	(41,025)		15,442		(25,583)
Accounts payable	(191,871)		28,500		(163,371)
Accrued expenses	145,704		21,521		167,225
Other Assets and Liabilities	(45,015)		(38,316)		(83,331)
Net cash provided by operating activities	30,404		(1,570)		28,834
Other, net	(4,073)		(937)		(5,010)
Net cash used in financing activities	204,984		(937)		204,047
Effect of exchange rate changes on cash	(1,942)		10		(1,932)
Net (decrease) increase in cash and cash equivalents	48,246		(2,497)		45,749
Cash and cash equivalents, beginning of period	269,282		1,523		270,805
Cash and cash equivalents, end of period	$	317,528	$	(974)	$	316,554